Anxiety disorders are the most common mental health diagnoses in the United States, and yet a substantial proportion of people with generalized anxiety disorder, social anxiety, panic disorder, or OCD experience inadequate relief from first-line treatments including SSRIs, SNRIs, and cognitive-behavioral therapy. For those patients, the clinical conversation often stalls at “try another medication” — a cycle that can extend for years without producing the quality of relief that would allow a person to genuinely live their life. At Nomad Therapeutics, we see many Seattle-area patients who are in exactly this position, and we offer ketamine-assisted psychotherapy as a clinically grounded alternative for those whose anxiety has not responded to standard care.
The Neurobiology of Treatment-Resistant Anxiety
Anxiety, at a neurobiological level, involves dysregulation across multiple brain systems — the amygdala’s threat detection circuits, the prefrontal cortex’s capacity for rational appraisal and inhibitory control, and the complex interplay between stress hormones and neural plasticity. Conventional anxiolytics and antidepressants work primarily by modulating serotonin, GABA, or norepinephrine systems. For patients whose anxiety is driven by patterns that do not respond to these approaches — rigid cognitive structures, deeply entrenched avoidance behaviors, or trauma-driven hyperarousal — a different mechanism may be needed.
Ketamine’s potential in anxiety treatment lies in its neuroplastic effects and its ability to temporarily loosen the rigid cognitive and behavioral patterns that maintain anxiety. By acting on NMDA glutamate receptors and triggering rapid BDNF production, ketamine promotes synaptic plasticity and can facilitate the kind of neural reorganization that makes new learning possible. For anxious patients, this window of enhanced plasticity — when paired with deliberate therapeutic work — may allow them to engage differently with feared situations, catastrophic thought patterns, and avoidance behaviors. Ketamine’s use for anxiety is off-label; it is not FDA-approved for anxiety disorders, and individual results vary. Patients should discuss the clinical evidence and their specific presentation with a qualified provider before making decisions about this approach.
How Nomad Therapeutics Structures KAP for Anxiety
At Nomad Therapeutics, our KAP model for anxiety involves the same three-phase structure we use with all patients: preparation, ketamine administration, and integration. The preparation phase is particularly important in anxiety treatment because many anxious patients approach a new clinical procedure with significant apprehension. We spend time during preparation addressing that apprehension directly — explaining what the ketamine experience involves, what the nurse’s role is during the session, what common sensations and perceptions arise, and how the patient can use specific anchoring techniques if the experience becomes uncomfortable. Arriving to the session having genuinely processed what to expect is a meaningful predictor of how well the experience goes. You can learn more about what this looks like in practice in our post on the three phases of ketamine-assisted psychotherapy.
The At-Home Advantage for Anxious Patients
Our at-home delivery model offers a specific advantage for anxious patients: the elimination of the clinical environment itself as a trigger. Many people with anxiety disorders have conditioned associations with medical offices, waiting rooms, and hospital settings — elevated heart rate, heightened vigilance, and the cognitive interference of a stress response before the treatment has even begun. By bringing the nurse to the patient’s home in Seattle, we ensure that the patient begins the session in the most comfortable environment available to them. The playlist they chose, the lighting they prefer, the blanket on their own couch — these details are not trivial; they are the set and setting that clinical literature consistently identifies as meaningful to therapeutic outcomes. Our at-home ketamine therapy for anxiety treatment is designed specifically with this in mind.
Addressing Therapeutic Hopelessness
A barrier we frequently encounter with anxiety patients is what might be called therapeutic hopelessness — the entrenched belief, forged by years of inadequate treatment response, that nothing more can be done. This belief is psychologically understandable and, paradoxically, one of the things that anxiety itself produces: the anxious mind is exceptionally good at anticipating failure and building cognitive cases for not trying. We approach this pattern with genuine compassion rather than dismissiveness. We do not guarantee outcomes — results vary by individual, and we have no interest in overselling a treatment to patients who deserve honest information. But we do offer the reasonable, evidence-supported position that a different mechanism targeting different neural systems may produce a different result.
How KAP Fits Alongside Existing Treatment
A second barrier involves the question of how KAP fits alongside existing treatment. Many patients we see are already working with a therapist and may be taking prescribed medication. KAP is not necessarily a replacement for either; it can be a complementary intervention that creates conditions for existing therapeutic work to go deeper. We always encourage patients to discuss with their provider how KAP might fit into their current treatment picture rather than treating it as an either-or decision. Our intake process includes a review of current medications and any safety considerations for combining ketamine with existing prescriptions. For a full overview of the conditions ketamine treats, including how anxiety co-occurs with depression and PTSD, visit our conditions page.
We serve adults in Seattle and the broader Pacific Northwest who are living with anxiety that has not responded to the treatments they have already tried. If that description fits your situation, we encourage you to reach out for an honest conversation about whether KAP might be appropriate for you.
Frequently Asked Questions
Which anxiety disorders does Nomad Therapeutics work with?
We work with patients who have generalized anxiety disorder, social anxiety disorder, panic disorder, OCD, and anxiety that co-occurs with depression or PTSD. Each patient is evaluated individually to determine whether KAP is clinically appropriate for their specific presentation.
Can ketamine make anxiety worse?
Some patients experience transient anxiety during or immediately after a ketamine session, which is one reason preparation and nurse presence throughout the session are essential. Our clinical protocols and preparation sessions are specifically designed to minimize this risk and to give patients tools for navigating any discomfort that arises.
How does the at-home setting help anxious patients?
Anxious patients often have conditioned associations with medical environments that raise their baseline stress response before treatment begins. Being in their own home removes this additional layer of anxiety and allows them to arrive at the session in a more grounded state.
Do I need to stop my current anxiety medications to start KAP?
Medication management decisions depend on your specific medications and clinical situation. Some medications interact with ketamine and may require adjustment; others do not. This is assessed individually during our intake evaluation. We never advise stopping a prescribed medication without a healthcare provider’s guidance.
How many sessions are typically needed for anxiety treatment?
Treatment is individualized. Some patients notice meaningful change within a few sessions; others benefit from a longer course. We develop a personalized plan during the intake evaluation and adjust as treatment progresses.
Key Takeaways
- Anxiety disorders have high rates of inadequate response to first-line treatments, and patients who have not responded to SSRIs or CBT may benefit from a different neurobiological approach.
- Ketamine’s neuroplastic effects may help loosen the rigid cognitive and behavioral patterns that maintain anxiety, though its use for anxiety is off-label and individual results vary.
- The preparation phase of KAP is especially important for anxious patients, providing detailed anticipatory guidance and reducing procedural anxiety.
- Nomad Therapeutics’ at-home delivery model removes the clinical environment itself as an anxiety trigger, supporting a more settled starting state for each session.
- KAP can complement rather than replace existing therapy and medication — patients should discuss with their provider how it fits into their overall treatment plan.
Conclusion
For Seattle-area patients who have tried multiple medications and multiple therapeutic approaches without achieving the quality of anxiety relief they deserve, ketamine-assisted psychotherapy represents a meaningfully different path — different mechanism, different delivery, and different therapeutic container than anything they have likely tried before. We do not promise a specific outcome, because results vary by individual and honesty matters more to us than a compelling pitch. What we do offer is a rigorous, evidence-informed evaluation and a model built to give treatment the best possible chance of working. Schedule a consultation with the Nomad Therapeutics team to learn whether KAP is a good fit for your situation.
References
Anxiety and Depression Association of America. https://adaa.org/
National Institutes of Health, Anxiety Disorders. https://www.nimh.nih.gov/health/topics/anxiety-disorders
Journal of Affective Disorders, Ketamine and Anxiety. https://www.journals.elsevier.com/journal-of-affective-disorders
American Psychiatric Association, Anxiety Treatment Guidelines. https://www.psychiatry.org/psychiatrists/practice/clinical-practice-guidelines
About Nomad Therapeutics Team
At Nomad Therapeutics in Seattle, our team delivers ketamine-assisted psychotherapy in the patient’s home, combining registered nurse–administered ketamine with preparation and integration therapy for a complete treatment model. We work specifically with patients who have not found adequate relief through conventional antidepressant treatment, starting every evaluation by taking the patient’s full history seriously and identifying what clinical picture it reveals. Our structured KAP model — preparation before each session, medication delivered by a nurse, and integration therapy afterward — is designed to make ketamine’s neuroplastic window translate into lasting therapeutic change for patients with treatment-resistant depression in the Seattle area.
Medical Disclaimer
The content on this page is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Ketamine therapy is not FDA-approved for anxiety disorders or any other psychiatric condition; its use in these contexts is off-label and should be discussed thoroughly with a qualified healthcare provider. Results vary by individual, and no specific outcome is guaranteed. If you are experiencing a mental health crisis or emergency, please contact 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room. Always discuss treatment options, risks, and benefits with your provider before making any healthcare decisions.